SCHEMBL669403

SCHEMBL669403

O=C(Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 11/20 0.55
MAPT P10636 4/20 0.55
MEN1 O00255 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
CA9 Q16790 3/20 0.45
CA12 O43570 2/20 0.45
POLB P06746 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
NPBWR1 P48145 1/20 0.43
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
HSD17B10 Q99714 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PARP10 Q53GL7 1/20 0.39
GRM5 P41594 1/20 0.38
PRKDC P78527 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15541454 0.93 KMT2A (0.51) KMT2AMAPTMEN1TDP1CA9
SCHEMBL23199773 0.85 HSD17B10 (0.44) KMT2AMAPTMEN1TDP1POLB
SCHEMBL9937599 0.84 KMT2A (0.53) KMT2AMAPTMEN1TDP1ALDH1A1
SCHEMBL9937518 0.83 KMT2A (0.38) KMT2AMAPTMEN1TDP1POLB
SCHEMBL996026 0.83 CA12 (0.41) KMT2AMAPTMEN1TDP1CA9
SCHEMBL668901 0.83 CA12 (0.41) KMT2AMAPTMEN1TDP1CA9
SCHEMBL9937557 0.82 MAPT (0.41) KMT2AMAPTMEN1TDP1POLB
SCHEMBL19253296 0.81 NCEH1 (0.30) KMT2AMAPTMEN1
SCHEMBL26104675 0.81 MEN1 (0.30) KMT2AMAPTMEN1
SCHEMBL9938274 0.80 ELANE (0.38) TDP1CA9CA12ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed
WO-2012022880-A2 METHOD FOR SYNTHESIZING STEROIDS UNIVERSITE DE STRASBOURG (FR) 2012-02-23 WO disclosed